ESTABLISHMENT OF SYSTEMATIC TYPES OF FUNGI THAT ARE THE CAUSATIVE AGENT OF TRICHODERMA
Keywords:
Keywords Trichoderma, Phialospore Colony Mycelium Gyphus Strain Phialis Conidiaphore, Conidia SpeciesAbstract
Abstract Studying Trichoderma species represents a large practical and theoretical interest in connection with their use in human activities. The widespread use of these mushrooms requires the study of their environmental features, species diversi-ty.Trichoderma fungi are widespread in nature. The systematic position of fungi of the genus Trichoderma studied from soil samples of the Bukhara region. Isolated fungus according to the identifier Rifai are classified as Trichoderma koningi, Trichoderma harzianum, Trichoderma aureoviride, Trichoderma longibrachiatum.
References
Samuels G.J, Suarez C, Solis K, Holmes K.A., Thomas S.E., Ismaiel A, Evans H.C. 2006 Trichoderma the obromicola and T. paucisporum: two new species isolated from cacao in South America. Mycological Research.110: 381–392.
Samuels G.J. 1996. Trichoderma: a review of biology and systematic of the genus. Mycology Research. 100: 923-935.
Kubicek C.P., Mach R.L., Peterbauer C.K., Lorito M. Trichoderma: from genes to biocontrol // Journal of Plant Pathology. 2001. Vol. 83. p 11— 23.
Rifai M.A. 1969. A revision of the genus Trichoderma.Mycological Papers.116: 1-56.
Bissett J. 1984. A revision of the genus Trichoderma. I. Section Longibrachiatum. Can. J. Bot. 62: 924-931.
Bissett J. 1991. A revision of the genus Trichoderma. II. Infrageneric classification. Can. J. Bot. 69: 2357–2372.
Gams W, Bissett J. 1998. Morphology and identification of Trichoderma.In Trichoderma and Gliocladium, (Eds) by C. P. Kubicek& G. E. Harman. London; Bristol, PA: Taylor & Francis. 3-31.
124. Bissett S. A revision of the genus Trichoderma // Cañad. J. Bot. 1984. -No 64. - P.2373-2417.
White, T. J., Bruns, T., Lee, S., and Taylor, J. (1990). “Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics,” in: PCR Protocols: A
Guide to Methods and Applications, M. A. Innis, D. H. Gelfand, J. J. Sninsky, and T. J. White (eds.), Academic Press, New York, NY, pp.315-322.
Лапасов, О. А., & Латипов, И. И. (2022). Базальноклеточный рак кожи. Исторические аспекты, актуальные достижения и проблемы на современном этапе. Central Asian Journal of Medical and Natural Science, 3(5), 381-391.
Latipov, I. I., & Lapasov, O. A. (2022). Histopathology of basal cell cancer. European journal of modern medicine and practice, 2(10), 108-119.
Latipov, I. I. (2023). The results of the clinical effectiveness of the treatment of patients with vitiligo as a result of treatment with the developed modified immunocorrective complex therapy. World Bulletin of Public Health, 22, 74-79.
Latipov, I. I., Axmedovich, M. F., & Hamzao'g'li, O. J. (2021). Evaluationofthequalityoflifeofvitiligopatientsbytheeffectivenessofcombinationtherapyusingthedermatologylifequalityindex (DLQI). WebofScientist: InternationalScientificResearchJournal, 2(10), 55-63.
Latipov, I. I., & Lapasov, O. A. (2022). Improvement of Methods for Early Diagnosis of Basalcellskincancer. International journal of health systems and medical sciences, 1(4), 74-80.
Bakhtiyorovich, K. B., & Ikromovich, L. I. (2022). Psychosocial impact on a healthy lifestyle of patients with vitiligo among the population of Uzbekistan. ACADEMICIA: An International Multidisciplinary Research Journal, 12(7), 197-204.
Ikromovich, L. I., & Bakhtiyorovich, K. B. (2022). Vitiligo: Modern views on etiology, pathogenesis and therapy methods.
Latipov, I., & Kholov, B. (2022). Studying the effectiveness and safety of the influence of medium doses of uva-1 radiation on the clinical manifestations of psoriasis. Academic research in modern science, 1(11), 56-63.
